Additional information regarding demands from certain bondholders

Today, Essity has received information that a minority of investors, in some of its Luxembourg-listed bond series, have initiated proceedings in English court.

Referring to the press release dated October 17, 2024, regarding demands from a few bondholders and bonds issued by Essity, the company has been made aware that some of these investors have initiated proceedings in an English court. The investors' holdings represent a small portion of the outstanding bonds. As previously communicated, Essity rejects the claim that there is a right to early repayment under the terms of these bonds and considers the demand to be unfounded. 

For further information, please contact:
Per Lorentz, Vice President Corporate Communications, +46 73 313 30 55, per.lorentz@essity.com
Sandra Åberg, Vice President Investor Relations, +46 70 564 96 89, sandra.aberg@essity.com

Essity is a global, leading hygiene and health company. Every day, our products, solutions and services are used by a billion people around the world. Our purpose is to break barriers to well-being for the benefit of consumers, patients, caregivers, customers and society. Sales are conducted in approximately 150 countries under the leading global brands TENA and Tork, and other strong brands such as Actimove, Cutimed, JOBST, Knix, Leukoplast, Libero, Libresse, Lotus, Modibodi, Nosotras, Saba, Tempo, TOM Organic and Zewa. In 2023, Essity had net sales of approximately SEK 147bn (EUR 13bn) and employed 36,000 people. The company’s headquarters is located in Stockholm, Sweden and Essity is listed on Nasdaq Stockholm. More information at essity.com.